Seeking Alpha

Shire plc (SHPGY)

()

News & PR
Market Currents

Buzz
Twitter: SHPGY

Business Intelligence
Transcripts
Events
Key Developments

Analysis - Latest Articles by most recent | most commented

Shire Seeks FDA Approval for Replagal

Dec 28 • Zacks.com • Comment!
Ten Most Attractive FTSE 100 Stocks

Dec 20 • Value Expectations • 1 Comment
European Equities Lower on Momentum Change

Dec 17 • The LFB • Comment!
Even as S&P 500 Rises, There Are Remaining Bright Spots Among DRs

Dec 3 • Global Investing Editor • 2 Comments
Lumizyme Rejected Again: Downgrading Genzyme Recommendation from Buy to Hold

Nov 17 • Mark Mitchell • Comment!
Genzyme: Haunted by Contamination

Nov 16 • Zacks.com • Comment!
Developments for Parkinson's Disease Ignite Investor Enthusiasm

Nov 16 • Michael Becker • 5 Comments
Genzyme: Focusing on Lumizyme Approval

Oct 30 • Mark Mitchell • Comment!
BioMed News: Antigenics, Shire, King Pharma, Delcath Systems

Oct 21 • Mike Havrilla • 29 Comments
Trial Setback Is Welcome News for Genzyme, But Don't Get Too Excited

Oct 6 • Mark Mitchell • 3 Comments
Sell Genzyme Near Term Due to Continued Manufacturing Challenges

Sep 24 • Mark Mitchell • 2 Comments
Tuesday Options Update: M, MBI, JDSU & SHPGY

Sep 22 • Andrew Wilkinson • Comment!
Genzyme: Short Term Traders Are Throwing Out the Baby with the Bathwater

Sep 16 • Ken Majmudar • Comment!
Clolar Decision Aside, Genzyme's Still a Near-Term Sell

Sep 2 • Mark Mitchell • Comment!
Protalix Biotherapeutics: FDA Fast Track for Gaucher Treatment

Aug 26 • BioPharma Investor • 4 Comments
Biotech Dealmaking Takes a Summer Breather

Aug 23 • The Burrill Report • Comment!
Closing Update for Wednesday, August 19: Stocks (and Crude) Scratch Back

Aug 19 • Midnight Trader • 1 Comment
Genzyme: More Negative News

Aug 18 • Mark Mitchell • 3 Comments
Genzyme Takes No Chances with Cerezyme Product

Aug 12 • Mark Mitchell • Comment!
Genzyme’s Problems Continue

Aug 9 • Zacks.com • 1 Comment
Investing Outside the U.S.: 12 Stocks Worth Considering

Aug 6 • Global Investing Editor • 4 Comments
FDA Calendar Updates: Achillion Pharma, Roche, Genzyme, Protalix, Shire

Jul 31 • Mike Havrilla • Comment!
FDA Calendar Updates: Schering-Plough, Shire, Elron Electronics, Cardium

Jul 28 • Mike Havrilla • Comment!
Genzyme's Manufacturing Disruption Highlights Investment Opportunities

Jul 20 • Michael Becker • 4 Comments
U.K.'s Ten Best Stocks

Jul 15 • Value Expectations • Comment!
FDA Calendar Updates: Oxford, Protalix, Spectrum, Shire

Jul 7 • Mike Havrilla • 1 Comment
Comparing Medicine’s Cost and Effectiveness

Jul 1 • Eric Savitz • 6 Comments
Pharma Announces $80B Reduction: Who Wins?

Jun 23 • Larry Rothman • 1 Comment
FDA Calendar Updates: Acusphere, AspenBio, Alkermes

May 19 • Mike Havrilla • 3 Comments
20 'Bathwater Babies' and 20 'Dogs with Fleas' Stocks for the Week

May 4 • J Clinton Hill • 2 Comments
Galleon's Q408: SPY Pays Off Alongside Reduced Equity Positions

Apr 21 • Market Folly • Comment!
Where Might Genentech Investors Redeploy $47B?

Mar 16 • Michael Becker • 2 Comments
Corporate Flight from the U.S. - The Next Step?

Feb 27 • Michael Cohen • 7 Comments
20 'Babies with Bathwater' and 3 'Dogs with Fleas' for the Week

Feb 23 • J Clinton Hill • 1 Comment
Five Autism Stocks

Feb 16 • Stockerblog • 1 Comment
Autism in the News - and Stocks that Could Benefit

Feb 13 • Stockerblog • 2 Comments
What to Buy and Why: Barron's 2009 Roundtable, Part III

Jan 25 • SA Editor Eli Hoffmann • 19 Comments
Hedge Fund Tracking: Barry Rosenstein's Jana Partners, Q3 2008

Dec 24, 2008 • Market Folly • 3 Comments
Tuesday Options Update: VIX, XLF, YHOO, IRM, SHPGY, SKX, NTES, BBBY

Sep 23, 2008 • Andrew Wilkinson • 1 Comment
Shire May Have Another Winner in Purchase of Jerini

Jul 7, 2008 • Eben Tessari • Comment!
Tuesday's Options Report: XLF, MS,LEH, GS, EWJ, SRZ, SHPGY, INTU

Mar 18, 2008 • Andrew Wilkinson • Comment!

Shire plc (SHPGY)

Analysis - Latest Articles by most recent | most commented

The Seeking Alpha 100

Fastest Climbers

Top Commenters

Top Instabloggers

Top StockTalkers